Document is current
Any future updates will be listed below
-
Authors
Alcalde-Herraiz, Marta
Iqbal, Shahed
Wallin, Jeffrey J.
Liu, Yunhao
Nieves, Wildaliz
Berry, Mark
Catala, Marti
Prieto-Alhambra, Daniel https://orcid.org/0000-0002-3950-6346
Xie, Junqing https://orcid.org/0000-0002-0040-0042
-
Funding
Funding for this research was provided by:
DH | NIHR | Health Services and Delivery Research Programme (SRF-2018-11-ST2-004).)
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 18 July 2025
First Online: 30 July 2025
Competing interests
: DPA research group from the University of Oxford has received research grants from the European Medicines Agency, from the Innovative Medicines Initiative, from Gilead Science, and from UCB Biopharma. S.I., J.J.W., W.N., Y.L., and M.B. are employees of Gilead Sciences and may own stock in the company. The remaining authors declare no competing interests.
